Trial intelligence / Profile preview

Safety and Immunogenicity of ACYW135 Meningococcal Polysaccharide Vaccine in 2-50 Years Old

NCT02869672Phase 3Unknown

Sponsor
Beijing Chaoyang District Center for Disease Control and Prevention
Start
Jul 2016
Primary completion
Dec 2016
Modality
Vaccines & Immunotherapeutics
01

Overview

A Phase 3 trial of ACYW135 meningococcal polysaccharide vaccine in meningococcal disease, sponsored by Beijing Chaoyang District Center for Disease Control and Prevention. Status: unknown.

02

Drugs

ACYW135 meningococcal polysaccharide vaccine
03

Conditions

meningococcal disease

Beyond the preview

Go deeper on NCT02869672.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02869672.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call